(Q37610265)

21 August 2017

title

Genomics of immune molecules: early detection of cognitive decline and new therapeutic interventions (English)

1 reference

21 August 2017

0 references

Federico Licastro

1

1 reference

21 August 2017

publication date

1 September 2002

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

21 August 2017

published in

1 reference

21 August 2017

volume

2

1 reference

21 August 2017

issue

5

1 reference

21 August 2017

page(s)

639-645

1 reference

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2.5.639

Apolipoprotein E polymorphism and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2.5.639

Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2.5.639

Interleukin-6 and α-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2.5.639

Distribution of interleukin-1-immunoreactive microglia in cerebral cortical layers: implications for neuritic plaque formation in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2.5.639

The importance of inflammatory mechanisms in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2.5.639

Circulating cytokines in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2.5.639

Increased levels of alpha-1-antichymotrypsin in brains of patients with Alzheimer's disease correlate with activated astrocytes and are affected by APOE 4 genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2.5.639

Human plasma proteinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2.5.639

Alpha 1-antichymotrypsin and IL-1 beta are not increased in CSF or serum in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2.5.639

No genetic effect of alpha1-antichymotrypsin in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2.5.639

Apolipoprotein E and alpha-1-antichymotrypsin allele polymorphism in sporadic and familial Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2.5.639

No association between the alpha 1-antichymotrypsin A allele and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2.5.639

Increased frequency of the alpha-1-antichymotrypsin T allele in cerebral amyloid angiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2.5.639

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2.5.639

A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2.5.639

A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2.5.639

Cytokines: Principles and prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.2.5.639

21 January 2018

Identifiers

DOI

10.1586/14737175.2.5.639

1 reference

21 August 2017

1 reference